Tradewinds Capital Management, LLC Abb Vie Inc. Transaction History

Tradewinds Capital Management, LLC

$372 Million
Q3 2024

A detailed history of Tradewinds Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 450 shares of ABBV stock, worth $81,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares

450

Previous 450 -0.0%

Holding current value

$81,000

Previous $77,000 14.29%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $7,991 - $9,105	-50 Reduced 10.0%	450 $81,000
Q3 2023 Oct 30, 2023	SELL	$133.59 - $154.65 $20,038 - $23,197	-150 Reduced 23.08%	500 $74,000
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $662 - $824	-5 Reduced 0.76%	650 $87,000
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $22,269 - $25,647	154 Added 30.74%	655 $104,000
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $22,129 - $26,539	160 Added 46.92%	501 $0
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $5,502 - $6,311	41 Added 13.67%	341 $46,000
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $189,640 - $241,094	-1,378 Reduced 82.12%	300 $46,000
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $21,486 - $27,186	200 Added 13.53%	1,678 $227,000
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $31,562 - $35,163	300 Added 25.47%	1,478 $166,000
Q3 2020 Oct 26, 2020	BUY	$85.91 - $100.83 $15,893 - $18,653	185 Added 18.63%	1,178 $103,000
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $14,013 - $18,752	-191 Reduced 16.13%	993 $97,000
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $23,736 - $35,986	-368 Reduced 23.71%	1,184 $90,000
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $5,049 - $6,317	70 Added 4.72%	1,552 $137,000
Q3 2019 Oct 17, 2019	SELL	$62.98 - $75.72 $12,910 - $15,522	-205 Reduced 12.15%	1,482 $112,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $13,994 - $17,887	-213 Reduced 11.21%	1,687 $123,000
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $7,868 - $9,260	-102 Reduced 5.09%	1,900 $153,000
Q4 2018 Jan 31, 2019	SELL	$77.85 - $96.01 $53,249 - $65,670	-684 Reduced 25.47%	2,002 $185,000
Q3 2018 Oct 31, 2018	BUY	$88.91 - $98.84 $266 - $296	3 Added 0.11%	2,686 $254,000
Q2 2018 Aug 06, 2018	BUY	$89.78 - $106.23 $16,519 - $19,546	184 Added 7.36%	2,683 $249,000
Q1 2018 May 02, 2018	BUY	$92.01 - $123.21 $20,978 - $28,091	228 Added 10.04%	2,499 $237,000
Q4 2017 Feb 01, 2018	BUY	$89.56 - $98.21 $89 - $98	1 Added 0.04%	2,271 $220,000
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $158,559 - $202,529	2,270	2,270 $202,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.

Account

Tradewinds Capital Management, LLC Abb Vie Inc. Transaction History